Table 1

Demographics and clinical characteristics of patients

Non-hemorrhageHemorrhageP value
(n=798)(n=61)
Age (years)57 (50–65)56 (48–65)0.478*
Male, n (%)572/798 (71.7)47/61 (77.0)0.368†
Risk factor, n (%)
 Smoking378/798 (47.4)33/61 (54.1)0.310†
 Alcohol intake326/798 (40.9)29/61 (47.5)0.307†
 History of stroke/TIA144/798 (18.0)13/61 (21.3)0.525†
 Hypertension522/798 (65.4)42/61 (68.9)0.586†
 Diabetes mellitus180/798 (22.6)20/61 (32.8)0.068†
 Hyperlipidemia88/798 (11.0)8/61 (13.1)0.631†
 Coronary heart disease66/798 (8.3)7/61 (11.5)0.387†
Statin therapy, n (%)
 Prior statin90/798 (11.3)8/61 (13.1)0.679†
 Present intensive statin289/798 (36.2)28/61 (45.9)0.126†
Scale score
 NIHSS3 (1–5)4 (2–9) 0.009*
Infarction cause, n (%)0.081†
 LAA201/720 (27.9)24/61 (39.3)
 SAO322/720 (44.7)19/61 (31.1)
 SOE and SUE197/720 (27.4)18/61 (29.5)
Infarction distribution, n (%)0.060†
 Anterior circulation196/720 (27.2)24/61 (39.3)
 Posterior circulation327/720 (45.4)19/61 (31.1)
 Anterior and posterior circulation197/720 (27.4)18/61 (29.5)
  • Categorical variables are presented as n (%), and continuous variables are presented as the median (IQR); p<0.05 was considered statistically significant.

  • *P value obtained by Mann–Whitney U test.

  • †P value obtained by χ 2 test.

  • SOE stroke of other determined etiology; LAA, large artery atherosclerosis; NIHSS, National Institutes of Health Stroke Scale; SAO, small artery occlusion; SUE, stroke of undetermined etiology; TIA, transient ischemic attack.